Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
PaperCitations, authors & open-access status
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 267 citations, 2021 year and hybrid oa status.
267
Citations
2021
Year
hybrid
OA Status